Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveDecreased adiponectin and increased leptin plasma concentrations are believed to be associated with the occurrence and progression of cancers such as endometrial cancer and breast cancer. The aim of this study was to explore the association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer. MethodsFor patients with ovarian cancer and the control group, adiponectin and leptin levels were measured; anthropometric data were obtained during a chart review. Statistical comparisons between groups were analyzed using the Student’s t-test; correlations were confirmed using the Pearson correlation. ResultsThe mean adiponectin and leptin concentrations in patients with ovarian cancer were lower than those of the control group (8.25 vs. 11.44 μg/mL, respectively; P=0.026) (7.09 vs. 15.4 ng/mL, respectively; P=0.001). However, there was no significant difference in adiponectin and leptin levels between early-stage (I/II) and advanced-stage (III/IV) disease (P=0.078). ConclusionCompared with other gynecological cancers, the level of adiponectin and leptin were decreased in ovarian cancer that may have some diagnostic value; additional study to elucidate the function of these two hormones in the development of ovarian carcinogenesis is necessitated.
Abstract
ObjectiveDecreased adiponectin and increased leptin plasma concentrations are believed to be associated with the occurrence and progression of cancers such as endometrial cancer and breast cancer. The aim of this study was to explore the association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer. MethodsFor patients with ovarian cancer and the control group, adiponectin and leptin levels were measured; anthropometric data were obtained during a chart review. Statistical comparisons between groups were analyzed using the Student’s t-test; correlations were confirmed using the Pearson correlation. ResultsThe mean adiponectin and leptin concentrations in patients with ovarian cancer were lower than those of the control group (8.25 vs. 11.44 μg/mL, respectively; P=0.026) (7.09 vs. 15.4 ng/mL, respectively; P=0.001). However, there was no significant difference in adiponectin and leptin levels between early-stage (I/II) and advanced-stage (III/IV) disease (P=0.078). ConclusionCompared with other gynecological cancers, the level of adiponectin and leptin were decreased in ovarian cancer that may have some diagnostic value; additional study to elucidate the function of these two hormones in the development of ovarian carcinogenesis is necessitated.
참고문헌 (30)
- Lu KH, "A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value", Cancer, 119, pp.3454~3461 (2013)
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62, pp.10~29 (2012)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
- Gnacinska M, "Role of adipokines in complications related to obesity: a review", Adv Med Sci, 54, pp.150~157 (2009)
- Hanley AJ, "Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans", J Clin Endocrinol Metab, 92, pp.2665~2671 (2007)
- Cong L, "Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2", Endocr Relat Cancer, 14, pp.713~720 (2007)
- Landskroner-Eiger S, "Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo", Clin Cancer Res, 15, pp.3265~3276 (2009)
- Oh DK, "Adiponectin in health and disease", Diabetes Obes Metab, 9, pp.282~289 (2007)
- Ouchi N, "Adiponectin as an anti-inflammatory factor", Clin Chim Acta, 380, pp.24~30 (2007)
- Owecki M, "Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI:high normal BMI is the threshold for serum leptin increase in humans", Horm Metab Res, 42, pp.585~589 (2010)
- Havel PJ, "Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women : effects of dietary fat content and sustained weight loss", J Clin Endocrinol Metab, 81, pp.4406~4413 (1996)
- Kimura E, "One-step enzyme-linked immunosorbent assay(ELISA)for measurement of serum free leptin", Clin Chim Acta, 296, pp.45~57 (2000)
- Yu Ma, "Serum leptin, adiponectin and endometrial cancer risk in Chinese women", Journal of Gynecologic Oncology, 24(4), pp.336~341 (2013), 대한부인종양학회
- Benedet JL, "FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology", Int J Gynaecol Obstet, 70, pp.209~262 (2000)
- Minatoya M, "Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study", Asian Pac J Cancer Prev, 15, pp.8325~8330 (2014)
- Thomas Reinehr, "Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents", Pediatric Diabetes, 17(4), pp.281~288 (2016), Wiley-Blackwell[DOI]
- Noda T, "Long term exposure to leptin enhances the growth of prostate cancer cells", Int J Oncol, 46, pp.1535~1542 (2015)
- Duan X, "Expression of leptin and adiponectin in esophageal squamous cell carcinoma and their clinical significance", Zhonghua Zhong Liu Za Zhi, 36, pp.839~843 (2014)
- Ptak A, "Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells", Endocrine, 43, pp.394~403 (2013)
- Tanaka M, "Role of central leptin signaling in the starvation-induced alteration of B-cell development", J Neurosci, 31, pp.8373~8380 (2011)
- Luhn P, "Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial", Cancer Epidemiol Biomarkers Prev, 22, pp.1304~1312 (2013)
- Grabowski JP, "Evaluation of leptin serum concentrations during surgery and first-line chemotherapy in primary epithelial ovarian cancer patients", Contemp Oncol (Pozn), 18, pp.318~322 (2014)
- Mor G, "Serum protein markers for early detection of ovarian cancer", Proc Natl Acad Sci U S A, 102, pp.7677~7682 (2005)
- Maccio A, "Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer : role of inflammation in cancerrelated anemia", Blood, 106, pp.362~367 (2005)
- Visintin I, "Diagnostic markers for early detection of ovarian cancer", Clin Cancer Res, 14, pp.1065~1072 (2008)
- Nick AM, "The ROC ‘n’ role of the multiplex assay for early detection of ovarian cancer", Nat Clin Pract Oncol, 5, pp.568~569 (2008)
- Ahima RS, "Role of leptin in the neuroendocrine response to fasting", Nature, 382, pp.250~252 (1996)
- Yang HP, "Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study", Int J Cancer, 131, pp.938~948 (2012)
- Hoskins WJ, "Prospective on ovarian cancer: why prevent?", J Cell Biochem Suppl, 23, pp.189~199 (1995)
- Matsubara M, "Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women", Eur J Endocrinol, 147, pp.173~180 (2002)